Jiangsu Aosaikang Biopharmaceutical Co., Ltd
Jiangsu Aosaikang Biopharmaceutical Co., Ltd
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma | gastric adenocarcinoma, gastroesophageal junction adenocarcinoma | Active, not recruiting | Phase 3 | 2026-09-16 | NCT06206733 | |
| A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors | Malignant Solid Tumor | Active, not recruiting | Phase 1 / Phase 2 | 2025-09-11 | NCT04632108 |